FADH2
Reactions involving FADH2
Every recorded step where this molecule takes part
-
FADH2 + NAD+ → FAD + NADH + H+
-
FADH2 + NAD+ → FAD + NADH + H+
-
Dihydrolipoamide + FAD → oxidized lipoamide + FADH2
-
Fatty acyl-CoA + FAD → trans-Δ2-enoyl-CoA + FADH2
-
produced Mitochondrial glycerol-3-phosphate dehydrogenase (GPD2) Glycerol-3-Phosphate Shuttle ST-0359
Glycerol-3-phosphate + FAD -> dihydroxyacetone phosphate + FADH2
-
Dihydrolipoamide-E2 + FAD → oxidized lipoamide-E2 + FADH2
Showing all 6 reactions.
Recent literature
Europe PMC · fetched just now · sorted by publication date
-
1
Combinatorial metabolic engineering of <i>Mycobacterium neoaurum</i> LY-2 for efficient androstenedione production from phytosterols.
Xu L, Peng C, Pan W, Tong Y, Shi J, Xu Z, Li H. · 2026-08-19
open access unreviewed -
2
Systematic enzyme and cofactor engineering for efficient ursolic acid biosynthesis in <i>Yarrowia lipolytica</i>.
Elsharawy H, He Q, Zeng W, Zhou J. · 2026-07-17
open access unreviewed -
3
Altered Acylcarnitine Metabolism in cardiac diseases: From molecular mechanisms to translational potential.
Wu J, Zhang Y, Liu J, Zhao W, Liu X, Dan J. · 2026-09-25
open access unreviewed -
4
Metabolic regulation of oocyte maturation and early embryo development in mammals.
Rong S, Fu Y, Li Y, Jiang YC, Chen L, Zhao Y, Zhu W, Mu L. · 2026-08-06
open access unreviewed -
5
Mechanistic pathways linking gut microbial metabolites, microbial structural products, and host-microbe co-metabolites to mitochondrial function.
Frye RE, Rossignol DA. · 2026-08-06
open access unreviewed -
6
Mucin-derived sugars act as metabolic brakes controlling growth initiation in <i>Akkermansia muciniphila</i>.
Lakey BD, Wozniak KJ, Britton RA, Tabor JJ. · 2026-06-26
open access unreviewed -
7
Systems engineering of <i>Escherichia coli</i> for high-level hydroxytyrosol production.
Zuo J, Zhang S, Huang W, Liu J, Gao C, Hu GP, Song W, Li X, Wei W, Wu J, Liu L, Liu K, Xu N. · 2026-06-01
open access unreviewed -
8
Targeting mitochondrial quality control in diabetic kidney disease: emerging therapeutic opportunities.
Luo J, Lu F, Cuciureanu M, Xu X, Dong H, Gong M. · 2026-02-03
cited 2× open access unreviewed -
9
Advances in the clinical applications of sodium thiosulphate.
Deng Y, Ke J, Zang H, Liu Y, Wang P. · 2026-01-05
cited 5× open access unreviewed -
10
The ketogenic diet is not for everyone: contraindications, side effects, and drug interactions.
Dyńka D, Rodzeń Ł, Rodzeń M, Łojko D, Karakuła-Juchnowicz H, Ede G, Grzywacz Ż, Antosik K, Sethi S, Unwin D. · 2026-01-04
cited 10× open access unreviewed
External claims. These come from an index outside this database and are not checked against it. Treat them as leads.